SouthState Corp’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Sell
22,204
-255
-1% -$14.9K 0.06% 182
2025
Q4
$1.21M Sell
22,459
-2,502
-10% -$120K 0.05% 185
2025
Q3
$1.13M Sell
24,961
-1,963
-7% -$91.7K 0.05% 184
2025
Q2
$1.25M Sell
26,924
-1,680
-6% -$82.5K 0.05% 181
2025
Q1
$1.74M Buy
28,604
+1,094
+4% +$63.8K 0.08% 156
2024
Q4
$1.56M Buy
27,510
+7
+0% +$391 0.1% 126
2024
Q3
$1.42M Sell
27,503
-894
-3% -$41.9K 0.1% 125
2024
Q2
$1.18M Sell
28,397
-3,599
-11% -$161K 0.09% 130
2024
Q1
$1.74M Buy
31,996
+1,297
+4% +$66.1K 0.14% 113
2023
Q4
$1.58M Sell
30,699
-439
-1% -$23K 0.13% 115
2023
Q3
$1.81M Sell
31,138
-5,049
-14% -$309K 0.17% 104
2023
Q2
$2.31M Sell
36,187
-2,425
-6% -$163K 0.21% 96
2023
Q1
$2.68M Sell
38,612
-1,396
-3% -$98.5K 0.25% 93
2022
Q4
$2.88M Sell
40,008
-3,718
-9% -$280K 0.27% 91
2022
Q3
$3.11M Sell
43,726
-1,283
-3% -$93.1K 0.31% 79
2022
Q2
$3.47M Sell
45,009
-247
-0.5% -$18.8K 0.33% 75
2022
Q1
$3.31M Buy
45,256
+3,645
+9% +$245K 0.26% 89
2021
Q4
$2.6M Buy
41,611
+1,256
+3% +$73.7K 0.2% 102
2021
Q3
$2.39M Sell
40,355
-600
-1% -$39.5K 0.2% 100
2021
Q2
$2.74M Sell
40,955
-119
-0.3% -$7.76K 0.24% 93
2021
Q1
$2.59M Sell
41,074
-696
-2% -$43.3K 0.24% 91
2020
Q4
$2.59M Sell
41,770
-1,078
-3% -$66.3K 0.26% 89
2020
Q3
$2.58M Buy
42,848
+828
+2% +$49.8K 0.27% 86
2020
Q2
$2.47M Sell
42,020
-1,918
-4% -$115K 0.3% 80
2020
Q1
$2.45M Sell
43,938
-5,099
-10% -$312K 0.36% 72
2019
Q4
$3.15M Buy
49,037
+12,103
+33% +$693K 0.36% 74
2019
Q3
$1.87M Hold
36,934
0.23% 99
2019
Q2
$1.68M Sell
36,934
-13,040
-26% -$607K 0.19% 105
2019
Q1
$2.38M Buy
49,974
+1,869
+4% +$93.1K 0.25% 96
2018
Q4
$2.5M Hold
48,105
0.29% 93
2018
Q3
$2.99M Buy
48,105
+1,185
+3% +$70.3K 0.31% 93
2018
Q2
$2.6M Sell
46,920
-1,418
-3% -$76.6K 0.29% 94
2018
Q1
$3.06M Sell
48,338
-4,410
-8% -$284K 0.35% 86
2017
Q4
$3.23M Sell
52,748
-1,504
-3% -$94.1K 0.35% 84
2017
Q3
$3.46K Sell
54,252
-499
-0.9% -$29.1K 0.39% 78
2017
Q2
$3.05M Sell
54,751
-3,874
-7% -$211K 0.39% 84
2017
Q1
$3.19M Buy
58,625
+13,276
+29% +$728K 0.42% 81
2016
Q4
$2.65M Sell
45,349
-2,475
-5% -$135K 0.38% 79
2016
Q3
$2.58M Hold
47,824
0.39% 80
2016
Q2
$3.52M Sell
47,824
-976
-2% -$69K 0.53% 68
2016
Q1
$3.12M Buy
48,800
+3,312
+7% +$209K 0.48% 74
2015
Q4
$3.13M Sell
45,488
-290
-0.6% -$19.2K 0.49% 74
2015
Q3
$2.71M Sell
45,778
-600
-1% -$38.1K 0.41% 83
2015
Q2
$3.09M Sell
46,378
-2,650
-5% -$175K 0.43% 82
2015
Q1
$3.16M Buy
49,028
+5,733
+13% +$359K 0.45% 77
2014
Q4
$2.56M Sell
43,295
-942
-2% -$53.1K 0.4% 82
2014
Q3
$2.26M Sell
44,237
-15,726
-26% -$786K 0.35% 87
2014
Q2
$2.91M Sell
59,963
-1,977
-3% -$97.4K 0.48% 71
2014
Q1
$3.22M Sell
61,940
-6,747
-10% -$359K 0.52% 69
2013
Q4
$3.65M Buy
68,687
+1,550
+2% +$79K 0.6% 60
2013
Q3
$3.11M Buy
67,137
+12,352
+23% +$542K 0.58% 62
2013
Q2
$2.45M Buy
+54,785
New +$2.38M 0.52% 67

Other funds holding BMY

SouthState Corp's BMY Position: Q1 2026 in Review

SouthState Corp reduced its Bristol-Myers Squibb (BMY) stake by 1.1% in Q1 2026, selling an estimated $14.9K and leaving 22,204 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #182.

SouthState Corp first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.65M in Q4 2013. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • SouthState Corp held 22,204 shares of Bristol-Myers Squibb worth $1.35M as of Q1 2026.
  • SouthState Corp sold 255 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.9K.
  • Bristol-Myers Squibb made up 0.06% of SouthState Corp's portfolio in Q1 2026, its #182 holding.
  • SouthState Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • SouthState Corp's Bristol-Myers Squibb position peaked at $3.65M in Q4 2013.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.